Skip to Content

Clinical Trials Details

SWOG S1117

Patient Information

SWOG S1117 - A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide (NSC-703813) vs. Azacitidine Alone Vs. Azacitidine in Combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Learn more about clinical trial - SWOG S1117

Study Number
SWOG S1117

Clinical Trial Categories

  • Hematology

Also in this Section